Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL309 Target Snapshot

Muscarinic acetylcholine receptor M2 · SINGLE PROTEIN · Rattus norvegicus

692Compounds
178Assays
22Approved Drugs
799.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P10980. Use UniProt P10980 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P10980 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Muscarinic acetylcholine receptor M2 as ChEMBL target CHEMBL309, mapped to UniProt P10980. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Muscarinic acetylcholine receptor M2
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL309
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P10980
Muscarinic acetylcholine receptor M2
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Muscarinic acetylcholine receptor M2 is the right protein anchor across sources, using UniProt P10980 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMuscarinic acetylcholine receptor M2
UniProt AccessionP10980
Component TypeProtein
Sequence Length466 aa

Muscarinic acetylcholine receptor M2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Muscarinic acetylcholine receptor M2, mapped to UniProt P10980. Sequence length is 466 aa.

Mapped IDP10980
Review nameMuscarinic acetylcholine receptor M2
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

22
Approved
7
Phase II
Assay Mix

Activity Type Distribution

IC50218.0
KI499.0
EC5033.0
KD49.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3298595 10.57 Ki 0.027 Preclinical
CHEMBL558910 10.52 Ki 0.03 Preclinical
CHEMBL3298599 10.28 Ki 0.053 Preclinical
CHEMBL119294 10.19 Ki 0.065 Preclinical
CHEMBL21812 10.0 Ki 0.1 Preclinical
CHEMBL3298596 9.92 Ki 0.12 Preclinical
CHEMBL47650 9.89 Ki 0.13 Preclinical
CHEMBL3545181 9.82 Ki 0.15 Approved
CHEMBL321214 9.75 Ki 0.177 Preclinical
CHEMBL12980 9.74 Ki 0.18 Preclinical
Distribution

pChEMBL Value Distribution

71
5.0
80
5.5
100
6.0
64
6.5
79
7.0
61
7.5
46
8.0
38
8.5
35
9.0
14
9.5
pChEMBL
Approved Drugs

Approved Drugs

XANOMELINE
CHEMBL21536
Approved 2024
TIOTROPIUM BROMIDE
CHEMBL3545181
Approved 2004
DARIFENACIN
CHEMBL1346
Approved 2004
SOLIFENACIN
CHEMBL1734
Approved 2004
TOLTERODINE
CHEMBL1382
Approved 1998
CLOZAPINE
CHEMBL42
Approved 1989
METHACHOLINE
CHEMBL978
Approved 1986
SCOPOLAMINE
CHEMBL569713
Approved 1979
OXYBUTYNIN
CHEMBL1231
Approved 1975
CARBACHOL
CHEMBL14
Approved 1972
HALOPERIDOL
CHEMBL54
Approved 1967
ATROPINE
CHEMBL517712
Approved 1960
BENZTROPINE
CHEMBL1201203
Approved 1954
DICYCLOMINE
CHEMBL1123
Approved 1950
Assay Landscape

Assay Landscape

179
Total Assays
537
Tested Compounds
3
Assay Types
Binding — 144 assays, 537 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 62 201 7.3
tissue-based format 33 134 6.5
assay format 30 129 6.8
cell membrane format 12 58 6.5
cell-based format 7 15 6.7
Functional — 34 assays, 20 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 17 6 5.5
tissue-based format 6 7 5.6
assay format 5 6 6.7
organism-based format 3 0
single protein format 2 1 5.2
cell membrane format 1 0
ADME — 1 assays, 2 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 2 7.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine